Long COVI Clinical Trials

1 recruiting

Long COVI Trials at a Glance

60 actively recruiting trials for long covi are listed on ClinicalTrialsFinder across 6 cities in 20 countries. The largest study group is Not Applicable with 24 trials, with the heaviest enrollment activity in Boston, Toronto, and San Francisco. Lead sponsors running long covi studies include Hong Kong Baptist University, ImmunityBio, Inc., and Massachusetts General Hospital.

Browse long covi trials by phase

Treatments under study

About Long COVI Clinical Trials

Looking for clinical trials for Long COVI? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Long COVI trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Long COVI clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 60 trials

Recruiting

Mitochondrial Function in Peripheral Blood Mononuclear Cells, Muscle, and Skin of Long COVID Patients

Long COVID
Universitair Ziekenhuis Brussel54 enrolled1 locationNCT07134673
Recruiting
Phase 3

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

Long COVID
Wes Ely550 enrolled16 locationsNCT06631287
Recruiting
Not Applicable

Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19

Long COVID-19 Syndrome
Fundación Cardioinfantil Instituto de Cardiología374 enrolled1 locationNCT06871293
Recruiting
Not Applicable

Long COVID Brain Fog: Cognitive Rehabilitation Trial

Cognitive ImpairmentCognitive DysfunctionPost-Acute COVID-19 Syndrome+2 more
University of Alabama at Birmingham30 enrolled1 locationNCT06095297
Recruiting
Phase 2

Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults With Post-COVID-19 Condition (PCC)

Post COVID-19 ConditionLong COVIDLong COVID Syndrome+2 more
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia90 enrolled1 locationNCT06766825
Recruiting
Phase 2Phase 3

Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)

Long COVIDSmell DysfunctionOlfactory Disorder
Medical University of South Carolina145 enrolled1 locationNCT05855369
Recruiting
Phase 3

Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study

Long COVID
Douglas D. Fraser348 enrolled9 locationsNCT06928272
Recruiting

Immune-mediated Pathogenic Mechanisms of Neuro-PASC in Veterans

Long COVIDNeuro-PASC
VA Office of Research and Development200 enrolled2 locationsNCT06932237
Recruiting
Phase 2

A Study to Assess Anktiva in Patients With Long Covid-19.

Long COVID
ImmunityBio, Inc.20 enrolled1 locationNCT07108036
Recruiting
Phase 2

DAOIB for the Treatment of Brain Fog

Long COVID
Chang Gung Memorial Hospital40 enrolled1 locationNCT05764538
Recruiting
Phase 2Phase 3

Taurine Supplementation in Long COVID

Long COVID
University of Alberta300 enrolled5 locationsNCT06721949
Recruiting

OUTComes POST Viral Infection: The OUTPOST study

Long COVIDInfluenzapost-infective fatigue syndrome
The University of Melbourne2,000 enrolled1 locationACTRN12626000290392
Recruiting
Phase 1

PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

Post Acute Sequelae of COVID-19Long COVID
National Institute of Mental Health (NIMH)60 enrolled1 locationNCT06920628
Recruiting

Long-Term Health Effects of Previous COVID-19 in Patients Undergoing Preoperative Anesthesia Evaluation

Long COVIDPost-COVID ConditionSequelae of COVID-19
Elazıg Fethi Sekin Sehir Hastanesi400 enrolled1 locationNCT07435805
Recruiting
Not Applicable

Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy for the Treatment of Post COVID Condition

Post Acute Sequelae of COVID-19Long COVID
University Health Network, Toronto120 enrolled1 locationNCT06452095
Recruiting

Persistent COVID-19 Registry in Navarre.

Long COVID SymptomsLong COVI
Fundacion Miguel Servet200 enrolled1 locationNCT07417176
Recruiting
Phase 2

NE3107 in Adults With Neurological Symptoms of Long COVID

Long COVID
BioVie Inc.208 enrolled20 locationsNCT06847191
Recruiting
Not Applicable

Mind Body Intervention for Long COVID-19

Long COVID
Beth Israel Deaconess Medical Center180 enrolled1 locationNCT06045338
Recruiting

Presynaptic Imaging in Major Depressive Episodes After COVID-19

Long COVIDMajor Depressive DisorderMajor Depressive Episode
Centre for Addiction and Mental Health90 enrolled1 locationNCT06086366
Recruiting
Not Applicable

Stellate Ganglion Block for Long COVID Symptoms: A Randomized Controlled Trial

Long COVID
Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec40 enrolled1 locationNCT07374562